Deutsche Bank raised the firm’s price target on Novartis (NVS) to CHF 120 from CHF 115 and keeps a Buy rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- Trump Weekly: Trump weighs stake in Intel, candidates for Fed Chair
- Pan-Tumor Rollover Study: A New Horizon in Long-term Cancer Treatment
- Novartis and Olema’s Phase 1b Breast Cancer Study: Market Watch
- Trump Trade: Pharma tariff announcement likely ‘weeks away’
- Pharma tariff announcement likely ‘weeks away,’ Reuters reports